×
Entrez Id: 5089
Gene Symbol: PBX2
PBX2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100
AlteredExpression
group
BEFREE
We detected p63 and p53 expression using immunohistochemistry staining in 84 cases of NKTCL from Southern of China, an area with a well known high incidence of nasopharyngeal carcinoma, which is closely associated with Epstein-Barr virus infection .
23626008 2013
×
Entrez Id: 1589
Gene Symbol: CYP21A2
CYP21A2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7917
Gene Symbol: BAG6
BAG6
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 80741
Gene Symbol: LY6G5C
LY6G5C
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100
GeneticVariation
group
BEFREE
Here, we report a rare case of gastrointestinal (GI)-ARL with MYC rearrangements and coinfected with Epstein-Barr virus (EBV) infection presenting with various endoscopic findings.
23922484 2013
TSBP1-AS1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 4609
Gene Symbol: MYC
MYC
0.100
GeneticVariation
group
BEFREE
These transformed tumors are clinically, histologically, and phenotypically similar to primary plasmablastic lymphomas, but they are not associated with immunodeficiency and rarely have Epstein-Barr virus infection or MYC alterations.
23282972 2013
×
Entrez Id: 1380
Gene Symbol: CR2
CR2
0.100
Biomarker
group
BEFREE
YCCEL1 cells expressed cytokeratin, but not CD21 and CD19, suggesting CD21 -independent EBV infection .
23175241 2013
HLA-DQB1
0.100
GeneticVariation
group
GWASCAT
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
EHMT2-AS1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100
GeneticVariation
group
BEFREE
The aim of this study was to investigate the clinicopathologic features, immunophenotype, T cell receptor (TCR) gene rearrangement, the association with Epstein-Barr virus (EBV) infection and p53 gene mutations of the lymphoma.
23557559 2013
×
Entrez Id: 58496
Gene Symbol: LY6G5B
LY6G5B
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
HLA-DQB1
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 10919
Gene Symbol: EHMT2
EHMT2
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 1460
Gene Symbol: CSNK2B
CSNK2B
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
HLA-DRB9
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100
AlteredExpression
group
BEFREE
In conclusion, EBV infection is associated with the expression of COX-2, p16(INK4A) and p53 .
24294363 2013
×
Entrez Id: 3122
Gene Symbol: HLA-DRA
HLA-DRA
0.100
GeneticVariation
group
GWASDB
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
23326239 2013
×
Entrez Id: 4068
Gene Symbol: SH2D1A
SH2D1A
0.100
GeneticVariation
group
BEFREE
Patients with the primary immunodeficiency X-linked lymphoproliferative disease (XLP), which is caused by mutations in SH2D1A , are highly susceptible to Epstein-Barr virus (EBV) infection .
22493517 2012
×
Entrez Id: 9260
Gene Symbol: PDLIM7
PDLIM7
0.100
Biomarker
group
BEFREE
Elucidation of the mechanisms involved in LMP1 -induced genomic instability in nasopharyngeal epithelial cells will shed lights on the understanding of role of EBV infection in NPC development.
22761726 2012
×
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100
Biomarker
group
BEFREE
In addition, we defined Epstein-Barr virus (EBV) infection as an alternative mechanism for PD-L1 induction in cHLs with diploid 9p24.1.
22271878 2012
×
Entrez Id: 3586
Gene Symbol: IL10
IL10
0.100
GeneticVariation
group
BEFREE
IL-10 rs1800871 (TC/CC) was associated with a reduced BC risk (OR, 0.74 [95% CI, 0.55-1.00]) but had no interaction with EBV infection on BC risk.22095765 2012
×
Entrez Id: 1380
Gene Symbol: CR2
CR2
0.100
Biomarker
group
BEFREE
LF prevented EBV infection of primary B cells mediated by its direct binding to the EBV receptor (CD21 ) on the B-cell surface.
22433582 2012
×
Entrez Id: 9260
Gene Symbol: PDLIM7
PDLIM7
0.100
AlteredExpression
group
BEFREE
However, despite documentation of EBV infection by expression of EBNA2 and LMP1 , B-CLL cells died after removal of macrophage feeder cells.
22160618 2012